journal article·2012-09

Gene-activated and cell-migration guiding PEG matrices based on three dimensional patterning of RGD peptides and DNA complexes

Silvia Orsi, Daniela Guarnieri, Antonia De Capua, Paolo A. Netti

Acta Biomaterialia· Volume 8· Issue 9
Publisher page

Abstract

Essential to the design of genetic bioreactors used in the human body is a consideration of how the properties of biomaterials can combine to envelope, spatially guide, reprogramme by gene transfer, and then release cells. In order to approach this goal, poly(ethylene glycol) (PEG) matrices with modulated structural features and defined spatial patterns of bioactive signals have been designed and produced. In particular, within such PEG matrices, both an adhesive RGD peptide gradient, to directionally attract NIH3T3 cells, and a designed spatial distribution of immobilized poly(ethylenimine) (PEI)/DNA complexes, to obtain a localized transfection, have been realized. These bioactive biomaterials have been designed bearing in mind that cells following an RGD gradient migrate through the matrix, in which they find the bound DNA and become transfected. Both cell migration and transfection have been monitored by fluorescence microscopy. Results show that this system is able to envelope cells, spatially guide them towards the immobilized gene complexes and locally transfect them. Therefore, the system, acting as a genetic bioreactor potentially useful for the regulation of biology at a distance, could be used to directly control cell trafficking and activation in the human body, and has many potential biomedical applications.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: 3D Printing in Biomedical Research · Cellular Mechanics and Interactions · Nanofabrication and Lithography Techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (52)

Show source-provided references
1. Inspiration and application in the evolution of biomaterials10.1038/nature08601 ↗
2. Infection-mimicking materials to program dendritic cells in situ10.1038/nmat2357 ↗
3. Covalent immobilization of RGDS on hydrogel surfaces to direct cell alignment and migration10.1016/j.jconrel.2005.09.020 ↗
4. Covalently immobilized gradients of bFGF on hydrogel scaffolds for directed cell migration10.1016/j.biomaterials.2004.09.021 ↗
5. For clinical phase I and II studies. Large-scale cGMP clinical manufacturing and quality assurance10.1007/978-1-4615-5357-1_74 ↗
6. Smart biomaterials – regulating cell behaviour through signaling molecules
7. Controlled spatial and conformational display of immobilized bone morphogenetic protein-2 and osteopontin signalling motifs regulates osteoblast adhesion and differentiation in vitro
8. Functional immobilization of signaling proteins enables control of stem cell fate10.1038/nmeth.1222 ↗
9. Spatiotemporal control over growth factor signaling for therapeutic neovascularization10.1016/j.addr.2007.08.012 ↗
10. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes10.1084/jem.115.3.453 ↗
11. Chemotaxis under agarose: a new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leucocytes and monocytes10.4049/jimmunol.115.6.1650 ↗
12. Cytokine-stimulated chemotaxis of human neutrophils in a 3-D conjoined fibrin gel assay10.1016/0022-1759(94)00314-M ↗
13. A fibrin or collagen gel assay for tissue cell chemotaxis: assessment of fibroblast chemotaxis to GRGDSP10.1006/excr.1998.4364 ↗
14. Design of novel 3D gene activated PEG scaffolds with ordered pore structure
15. Gene delivery with in-situ crosslinking polymer networks generates long-term systemic protein expression10.1016/S1525-0016(03)00008-X ↗
16. Controlled release systems for DNA delivery10.1016/j.ymthe.2004.03.020 ↗
17. Long-term in vivo gene expression via delivery of PEI-DNA condensates from porous polymer scaffold10.1089/hum.2005.16.609 ↗
18. Gene therapy vectors with enhanced transfection based on hydrolgels modified with affinity peptides10.1016/j.biomaterials.2011.03.083 ↗
19. Matrices and scaffolds for DNA delivery in tissue engineering
20. DNA delivery from polymer matrices for tissue engineering10.1038/9853 ↗
21. Cell recruitment and transfection in gene activated collagen matrix10.1016/j.biomaterials.2009.09.054 ↗
22. Covalently immobilized RGD gradient on PEG hydrogel scaffold influences cell migration parameters10.1016/j.actbio.2009.12.050 ↗
23. Solid phase peptide synthesis utilizing 9-fluorenylmethoxy-carbonyl amino acids10.1111/j.1399-3011.1990.tb00939.x ↗
24. Novel shielded transferrin-polyethylen glycol-polyethyleimine/DNA complexes for systemic tumor-targeted gene transfer10.1021/bc0256087 ↗
25. Evaluation of polyether-polyethyleneimine graft copolymers as gene transfer agents10.1038/sj.gt.3301052 ↗
26. Polyethylene glycol modified polyethylenimine for improbe CNS gene transfer: effects of PEGylation extent10.1016/S0142-9612(03)00029-2 ↗
27. Bioactive hydrogels with an ordered cellular structure combine interconnected macroporosity and robust mechanical properties10.1002/adma.200400507 ↗
28. A process for making microcellular thermoplastic parts10.1002/pen.760302010 ↗
29. Open-pore biodegradable foams prepared via gas foaming and microparticulate templating10.1002/mabi.200700278 ↗
30. Convection-driven generation of long-range material gradients10.1016/j.biomaterials.2009.12.012 ↗
31. Cell-based high content screening using an integrated microfluidic device10.1039/b711513j ↗
32. Microstructure and mechanical properties of poly(l-lactide) scaffolds fabricated by gelatine particle leaching method10.1002/app.22289 ↗
33. Polymer scaffolds with interconnected spherical pores and controlled architecture for tissue engineering: fabrication, mechanical properties, and finite element modeling10.1002/jbm.b.30683 ↗
34. Biodegradable polycaprolactone scaffold with controlled porosity obtained by modified particle-leaching technique
35. Fabrication of gradient hydrogels using a microfluidics/photopolymerization process10.1021/la049298n ↗
36. Incorporation of adhesion peptides into nonadhesive hydrogels useful for tissue resurfacing10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B ↗
37. Synthetic hydrogel niches that promote hMSC viability10.1016/j.matbio.2005.03.004 ↗
38. Enhancement of the adhesion of fibroblasts by peptide containing an Arg-Gly-Asp sequence with poly(ethylene glycol) into a thermo-reversible hydrogel as a synthetic extracellular matrix10.1007/s10529-004-8297-z ↗
39. Control of cell adhesion on poly(methyl methacrylate)10.1016/j.biomaterials.2005.12.009 ↗
40. An RGD spacing of 440 nm is sufficient for integrin alpha V beta 3-mediated fibroblast spreading and 140nm for focal contact and stress fiber formation10.1083/jcb.114.5.1089 ↗
41. Induction of cell polarization and migration by a gradient of nanoscale variation in adhesive ligand spacing10.1021/nl801483w ↗
42. Tumor cell haptotaxis on covalently immobilized linear and exponential gradients of a cell adhesion peptide10.1016/0012-1606(89)90159-0 ↗
43. Nanoscale cell adhesion ligand presentation regulates nonviral gene delivery and expression
44. Differential uptake of DNA-poly(ethylenimine) polyplexes in cells cultured on collagen and fibronectin surfaces10.1016/j.actbio.2010.03.038 ↗
45. DNA delivery from hyaluronic acid collagen hydrogels via a substrate-mediated approach10.1016/j.biomaterials.2004.05.007 ↗
46. Covalently immobilized biosignal molecule materials for tissue engineering10.1039/B708359A ↗
47. Transfection of cells mediated by degradable polymer materials with surface-bound polyethyleneimine10.1021/bp990150h ↗
48. Substrate-mediated DNA delivery: role of the cationic polymer structure and extent of modification10.1016/j.jconrel.2003.08.003 ↗
49. Vector unpacking as a potential barrier for receptor-mediated polyplex gene delivery10.1002/(SICI)1097-0290(20000305)67:5<598::AID-BIT10>3.0.CO;2-G ↗
50. Material-based deployment enhances efficacy of endothelial progenitor cells10.1073/pnas.0803873105 ↗
51. Viability and functionality of cells delivered from peptide conjugated scaffolds10.1016/j.biomaterials.2010.12.048 ↗
52. Sokal · 1969